These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8850391)

  • 1. Does plasma endothelin during thrombolysis depend on infarct size? A pilot study.
    Di Pasquale P; Paterna S; Parrinello G; Bucca V; Pipitone F; Tricoli G; Licata G
    Cardiovasc Drugs Ther; 1995 Dec; 9(6):831-2. PubMed ID: 8850391
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of captopril on plasma endothelin-1 during thrombolysis: preliminary findings.
    Di Pasquale P; Paterna S; Parrinello G; Bucca V; Caracausi R; Pipitone F; Licata G
    Cardiovasc Drugs Ther; 1995 Apr; 9(2):359-60. PubMed ID: 7662604
    [No Abstract]   [Full Text] [Related]  

  • 3. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.
    Cannon CP; McCabe CH; Henry TD; Schweiger MJ; Gibson RS; Mueller HS; Becker RC; Kleiman NS; Haugland JM; Anderson JL
    J Am Coll Cardiol; 1994 Apr; 23(5):993-1003. PubMed ID: 8144799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma immunoreactive endothelin in the acute and subacute phases of myocardial infarction in patients undergoing fibrinolysis.
    Lechleitner P; Genser N; Mair J; Maier J; Artner-Dworzak E; Dienstl F; Puschendorf B
    Clin Chem; 1993 Jun; 39(6):955-9. PubMed ID: 8504563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of mortality and morbidity during four years after late thrombolysis in acute myocardial infarct.
    Liguori A; DiGregorio F; Napoli C
    Heart; 1996 Sep; 76(3):291. PubMed ID: 8868993
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
    Cannon CP; McCabe CH; Diver DJ; Herson S; Greene RM; Shah PK; Sequeira RF; Leya F; Kirshenbaum JM; Magorien RD
    J Am Coll Cardiol; 1994 Dec; 24(7):1602-10. PubMed ID: 7963104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolysis: evidence for infarct size reduction.
    Martin GV; Ritchie JL
    J Am Coll Cardiol; 1991 Jun; 17(7):1458-60. PubMed ID: 1903405
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant tissue-type plasminogen activator: an infarct-sparing effect beyond thrombolysis?
    Kloner RA; Eisenhauer A
    J Am Coll Cardiol; 1992 Jul; 20(1):226-7. PubMed ID: 1607529
    [No Abstract]   [Full Text] [Related]  

  • 9. TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial.
    Cannon CP; McCabe CH; Gibson CM; Ghali M; Sequeira RF; McKendall GR; Breed J; Modi NB; Fox NL; Tracy RP; Love TW; Braunwald E
    Circulation; 1997 Jan; 95(2):351-6. PubMed ID: 9008448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombolysis in acute myocardial infarction].
    Rutsch W
    Dtsch Med Wochenschr; 1994 Sep; 119(36):1220-1. PubMed ID: 8082591
    [No Abstract]   [Full Text] [Related]  

  • 11. "Rescue" thrombolysis with intracoronary tissue plasminogen activator for failed intravenous thrombolysis with streptokinase for acute myocardial infarction.
    White HD; Cross DB; Williams BF; Norris RM; Woo KS; Hamer AW; Elliott JM; Ormiston JA
    Am J Cardiol; 1995 Jan; 75(2):172-4. PubMed ID: 7810496
    [No Abstract]   [Full Text] [Related]  

  • 12. Severity and response of chest pain during thrombolytic therapy for acute myocardial infarction: a useful indicator of myocardial salvage and infarct size.
    Christian TF; Gibbons RJ; Hopfenspirger MR; Gersh BJ
    J Am Coll Cardiol; 1993 Nov; 22(5):1311-6. PubMed ID: 8227785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after myocardial infarction: a multivariate analysis.
    de Chillou C; Riff P; Sadoul N; Ethevenot G; Feldmann L; Isaaz K; Simon JP; Boursier M; Khalifé K; Thisse JY; Aliot E
    J Am Coll Cardiol; 1996 Jun; 27(7):1662-8. PubMed ID: 8636551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience.
    Sloan MA; Price TR; Petito CK; Randall AM; Solomon RE; Terrin ML; Gore J; Collen D; Kleiman N; Feit F
    Neurology; 1995 Apr; 45(4):649-58. PubMed ID: 7723950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction.
    Andreotti F; Pasceri V; Hackett DR; Davies GJ; Haider AW; Maseri A
    N Engl J Med; 1996 Jan; 334(1):7-12. PubMed ID: 7494588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The prevention of reocclusion after thrombolysis in acute myocardial infarct: is tissue-type plasminogen activator really superior to streptokinase?].
    Negrini M
    G Ital Cardiol; 1995 Apr; 25(4):511-5. PubMed ID: 7677921
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombolysis in acute myocardial infarction.
    Holmberg SR
    Br J Hosp Med; 1992 Apr 15-May 5; 47(8):572-6, 578-80. PubMed ID: 1591557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril does not affect plasma endothelin-1 during thrombolysis and reperfusion.
    Di Pasquale P; Paterna S; Parrinello G; Bucca V; Cannizzaro S; Pipitone F; Maringhini G; Scalzo S; Licata G
    Int J Cardiol; 1995 Sep; 51(2):131-5. PubMed ID: 8522408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
    Steg PG; Laperche T; Golmard JL; Juliard JM; Benamer H; Himbert D; Aubry P
    J Am Coll Cardiol; 1998 Mar; 31(4):776-9. PubMed ID: 9525545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
    Baardman T; Hermens WT; Lenderink T; Molhoek GP; Grollier G; Pfisterer M; Simoons ML
    Eur Heart J; 1996 Feb; 17(2):237-46. PubMed ID: 8732377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.